EPOPROSTENOL Side Effects

6943849-3 | Candidiasis, Dysphagia, Epigastric Discomfort, Hypokalaemia, Nausea, Presyncope, Vulvovaginal Mycotic Infection
on Aug 23, 2010 Female patient from UNITED STATES , 42 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Epoprostenol (View Usage). Patient experienced the following unwanted or unexpected effects: candidiasis, dysphagia, epigastric discomfort, hypokalaemia, nausea (What is nausea?), presyncope, vulvovaginal mycotic infection. Epoprostenol dosage: . During the same period patient was treated with DEMADEX (View Demadex Review and Demadex Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6919895-2 | Candidiasis, Dysphagia, Hypokalaemia
Patient was taking Epoprostenol (View Usage). Patient had the following side effects: candidiasis, dysphagia, hypokalaemia on Aug 05, 2010 from UNITED STATES Additional patient health information: Female patient , 42 years of age, was diagnosed with pulmonary arterial hypertension and. Epoprostenol dosage: . During the same period patient was treated with DEMADEX (View Demadex Review and Demadex Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SINGULAIR (View Singulair Review and Singulair Label ), RHINOCORT (View Rhinocort Review and Rhinocort Label ). Patient was hospitalized.

6867183-5 | Chest Pain, Cough, Dizziness, Dyspnoea, Headache, Inflammatory Bowel Disease, Lethargy, Loss Of Consciousness, Nausea
Adverse event was reported on Jul 15, 2010 by a Female patient taking Epoprostenol (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED KINGDOM , weighting 125.7 lb, After Epoprostenol was administered, patient had the following side effects: chest pain (What is chest pain?), cough, dizziness (What is dizziness?), dyspnoea, headache (What is headache?), inflammatory bowel disease, lethargy, loss of consciousness, nausea (What is nausea?). During the same period patient was treated with SILDENAFIL CITRATE (80mg Three Times Per Day) (View Sildenafil Citrate Review and Sildenafil Citrate Label ), FRUMIL (View Frumil Review and Frumil Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6267363-6 | Atrial Septal Defect, Catheter Site Infection, Paradoxical Embolism, Transient Ischaemic Attack
on Jul 06, 2009 Female patient from SPAIN , 27 years of age, was treated with Epoprostenol (View Usage). Patient experienced the following unwanted or unexpected effects: atrial septal defect, catheter site infection, paradoxical embolism, transient ischaemic attack. Epoprostenol dosage: . During the same period patient was treated with TREPROSTINIL (View Treprostinil Review and Treprostinil Label ).


6264426-6 | Goitre, Hyperthyroidism, Thyroxine Increased
on Jul 01, 2009 Female patient from UNITED STATES , 30 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Epoprostenol (View Usage). Patient had the following side effects: goitre, hyperthyroidism, thyroxine increased. Epoprostenol dosage: .

6264425-4 | Goitre, Hyperthyroidism, Thyroxine Increased
Patient was taking Epoprostenol (View Usage). After Epoprostenol was administered, patient had the following side effects: goitre, hyperthyroidism, thyroxine increased on Jul 01, 2009 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with pulmonary arterial hypertension and. Epoprostenol dosage: .

5098760-2 | Gastric Ulcer, Gastrointestinal Haemorrhage, Helicobacter Infection
Adverse event was reported on Aug 25, 2006 by a Female patient taking Epoprostenol (View Usage) (Dosage: ) was diagnosed with crest syndrome, pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , 56 years of age, Patient experienced the following unwanted or unexpected effects: gastric ulcer, gastrointestinal haemorrhage, helicobacter infection. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), SILDENAFIL (80mg Three Times Per Day) (View Sildenafil Review and Sildenafil Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), DIHYDROCODEINE (View Dihydrocodeine Review and Dihydrocodeine Label ), LANSOPRAZOLE (30mg Per Day) (View Lansoprazole Review and Lansoprazole Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ). Patient was hospitalized.

5058104-9 | Body Temperature Increased, C-reactive Protein Increased, Chest Pain, Dyspnoea, Feeling Hot And Cold, Flushing, Headache, Hypotension, Palpitations
on Jul 17, 2006 Female patient from UNITED STATES , 49 years of age, weighting 156.5 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Epoprostenol (View Usage). Patient had the following side effects: body temperature increased, c-reactive protein increased, chest pain (What is chest pain?), dyspnoea, feeling hot and cold, flushing, headache (What is headache?), hypotension, palpitations. Epoprostenol dosage: . During the same period patient was treated with SILDENAFIL CITRATE (20mg Three Times Per Day) (View Sildenafil Citrate Review and Sildenafil Citrate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), CLEXANE (View Clexane Review and Clexane Label ), MEBEVERINE (View Mebeverine Review and Mebeverine Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

5019835-X | Atrial Fibrillation
on Jun 05, 2006 Male patient from UNITED STATES , 49 years of age, weighting 284.4 lb, was diagnosed with oxygen saturation decreased and was treated with Epoprostenol (View Usage). After Epoprostenol was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Epoprostenol dosage: 20 Ng/kg/min Inhaled.

5009659-1 | Chest Pain, Cough, Dizziness, Dyspnoea, Dyspnoea Exacerbated, Headache, Inflammatory Bowel Disease, Lethargy, Loss Of Consciousness
Patient was taking Epoprostenol (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), cough, dizziness (What is dizziness?), dyspnoea, dyspnoea exacerbated, headache (What is headache?), inflammatory bowel disease, lethargy, loss of consciousness on May 12, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 27 years of age, weighting 125.7 lb, . Epoprostenol dosage: . During the same period patient was treated with SILDENAFIL CITRATE (80mg Three Times Per Day) (View Sildenafil Citrate Review and Sildenafil Citrate Label ), FRUMIL (View Frumil Review and Frumil Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

5008279-2 | Diarrhoea, Vomiting
Adverse event was reported on Jan 09, 2006 by a Female patient taking Epoprostenol (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , 72 years of age, Patient had the following side effects: diarrhoea, vomiting. During the same period patient was treated with TRACLEER (125mg Twice Per Day) (View Tracleer Review and Tracleer Label ).

4662730-6 | Erythema, Vasculitic Rash
on May 04, 2005 Female patient from , 28 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Epoprostenol (View Usage). After Epoprostenol was administered, patient had the following side effects: erythema, vasculitic rash. Epoprostenol dosage: 65ngkm Per Day. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).

4662729-X | Oedema, Pain, Skin Discolouration, Vasculitic Rash
on May 04, 2005 Female patient from , 53 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Epoprostenol (View Usage). Patient experienced the following unwanted or unexpected effects: oedema, pain (What is pain?), skin discolouration, vasculitic rash. Epoprostenol dosage: 22ngkm Per Day. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

4662728-8 | Erythema, Leukocytoclastic Vasculitis, Pain, Palpable Purpura
Patient was taking Epoprostenol (View Usage). Patient had the following side effects: erythema, leukocytoclastic vasculitis, pain (What is pain?), palpable purpura on May 04, 2005 from Additional patient health information: Female patient , 54 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Epoprostenol dosage: 55ngkm Per Day. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

4611596-9 | Pulmonary Alveolar Haemorrhage
Adverse event was reported on Feb 22, 2005 by a Female patient taking Epoprostenol (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: , 24 years of age, After Epoprostenol was administered, patient had the following side effects: pulmonary alveolar haemorrhage. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

4611595-7 | Lung Transplant, Pulmonary Alveolar Haemorrhage
on Feb 22, 2005 Female patient from , 27 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Epoprostenol (View Usage). Patient experienced the following unwanted or unexpected effects: lung transplant (What is lung transplant?), pulmonary alveolar haemorrhage. Epoprostenol dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

4611594-5 | Pulmonary Alveolar Haemorrhage
on Feb 22, 2005 Female patient from , 23 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Epoprostenol (View Usage). Patient had the following side effects: pulmonary alveolar haemorrhage. Epoprostenol dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

4611593-3 | Pulmonary Alveolar Haemorrhage
Patient was taking Epoprostenol (View Usage). After Epoprostenol was administered, patient had the following side effects: pulmonary alveolar haemorrhage on Feb 22, 2005 from Additional patient health information: Female patient , 35 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Epoprostenol dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).